Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fahn

Showing results (251-260 of 407) with videos related to

Pageof 41
Sort By:
The Journal of Pharmacy and Pharmacology|July 1, 1976
Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnoverS R Snider, C Hutt, B Stein, et al.
The Laryngoscope|November 1, 1986
Botulinum toxin (BOTOX) for the treatment of "spastic dysphonia" as part of a trial of toxin injections for the treatment of other cranial dystoniasA Blitzer, M F Brin, S Fahn, et al.
Pharmacology, Biochemistry, and Behavior|April 1, 1989
The protein synthesis inhibitor, anisomycin, causes exacerbation of the iminodipropionitrile-induced spasmodic dyskinetic syndrome in ratsR Stennett, M Katz, V Jackson-Lewis, et al.
Psychopharmacology|January 1, 1985
Attenuation by electroshock treatment of the haloperidol-induced rise in the binding of 3H-imipramine to rat brain membranesA I Barkai, S Kowalik, A Reches, et al.
The Laryngoscope|February 1, 1992
Abductor laryngeal dystonia: a series treated with botulinum toxinA Blitzer, M F Brin, C Stewart, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 14, 1977
Is dopamine a neurohormone of the adrenal medulla? Studies with morphine stimulationS R Snider, C Miller, A L Prasad, et al.
Life Sciences|January 1, 1989
Monoamine oxidase inhibitory properties of milacemide in ratsD D Truong, B Diamond, G Pezzoli, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox)M F Brin, A Blitzer, S Fahn, et al.
Neurology|January 1, 1990
Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American familyT G Nygaard, J M Trugman, J G de Yebenes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 1992
What is it? Case 1, 1992: progressive gait deterioration, peripheral neuropathy, optic atrophy, bradykinesia, and dystonia in a young girlB S Russman, A E Lang, S Fahn, et al.
Pageof 41

Showing results (251-260 of 407) with videos related to

Sort By:
Pageof 41
The Journal of Pharmacy and Pharmacology|July 1, 1976
Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnoverS R Snider, C Hutt, B Stein, et al.
The Laryngoscope|November 1, 1986
Botulinum toxin (BOTOX) for the treatment of "spastic dysphonia" as part of a trial of toxin injections for the treatment of other cranial dystoniasA Blitzer, M F Brin, S Fahn, et al.
Pharmacology, Biochemistry, and Behavior|April 1, 1989
The protein synthesis inhibitor, anisomycin, causes exacerbation of the iminodipropionitrile-induced spasmodic dyskinetic syndrome in ratsR Stennett, M Katz, V Jackson-Lewis, et al.
Psychopharmacology|January 1, 1985
Attenuation by electroshock treatment of the haloperidol-induced rise in the binding of 3H-imipramine to rat brain membranesA I Barkai, S Kowalik, A Reches, et al.
The Laryngoscope|February 1, 1992
Abductor laryngeal dystonia: a series treated with botulinum toxinA Blitzer, M F Brin, C Stewart, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 14, 1977
Is dopamine a neurohormone of the adrenal medulla? Studies with morphine stimulationS R Snider, C Miller, A L Prasad, et al.
Life Sciences|January 1, 1989
Monoamine oxidase inhibitory properties of milacemide in ratsD D Truong, B Diamond, G Pezzoli, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox)M F Brin, A Blitzer, S Fahn, et al.
Neurology|January 1, 1990
Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American familyT G Nygaard, J M Trugman, J G de Yebenes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 1992
What is it? Case 1, 1992: progressive gait deterioration, peripheral neuropathy, optic atrophy, bradykinesia, and dystonia in a young girlB S Russman, A E Lang, S Fahn, et al.
Pageof 41